Over the last decade, we have begun to recognize that cancer poses an increasingly important public health threat and economic challenge in all countries. But what is not acknowledged is the disproportionate impact of cancer on the lives and livelihoods of women, and the downstream impacts this creates for societies at large.
In order to inform a nuanced, evidence-based, gendered approach to cancer risk and cancer control, The Lancet
Commission on Women and Cancer will address urgent and timely questions at the intersection of social inequality, cancer risk and outcomes, and the status of women in society.
The proposed Commission will not, however, be narrowly focused on women's cancers, nor solely on the gendered impacts of cancers that affect both women and men. Rather, the Commission will explore the nexus of gender, power, and cancer.